List view / Grid view
1 March 2016 | By Merck KGaA
With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analysing all the hallmarks of cancer...
26 February 2016 | By Rodrigo Barnes, Chief Technology Officer at Aridhia
Here, Rodrigo Barnes, Chief Technology Officer at Aridhia, discusses how data analytics can add value to proof of concept trials...
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
23 February 2016 | By DiscoverX Corporation
PathHunter cell-based pharmacotrafficking assays provide a simple and quantitative tool for broad pharmacological characterisation and interrogation of compound function in disease processes associated with protein trafficking and internalization due to protein misfolding...
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
19 February 2016 | By DiscoverX Corporation
Diversity PLUS Panel contains 12 human primary cell systems from multiple tissues that model human disease for predictive insight into drug efficacy and MOA...
18 February 2016 | By Select Biosciences
Select Biosciences is organizing its 2nd Annual World Congress focusing on Organs-on-Chips—an extremely important and cutting-edge field of important in basic research as well as pharmaceutical discovery and development...
18 February 2016 | By SELECTBIO
SELECTBIO is delighted to announce Organ-on-a-Chip Europe 2016, which will be held on 5 - 6 April in Cambridge, UK...
A concise overview of some of the key features for the use of antibodies and immunochemical techniques in biological research...
17 February 2016 | By Victoria White
The small peptide has been shown to be an effective at shuttling functional proteins into the spinal cord after a muscle injection...
15 February 2016 | By Victoria White
Researchers say drug discovery processes are becoming unsustainably expensive despite huge technological advances because the wrong methods are being used…
12 February 2016 | By DiscoverX Corporation
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients...
12 February 2016 | By DiscoverX Corporation
PathHunter® bioassays are cell-based assays that are highly validated, simple, and target specific to support biologics drug development...
9 February 2016 | By Dr Bissan Al-Lazikani and Elizabeth Coker, The Institute of Cancer Research, London
Dr Bissan Al-Lazikani and Elizabeth Coker discuss canSAR: the first public domain example of Big Data for drug discovery...
8 February 2016 | By SMi Group
SMi will open its doors to host RNA Therapeutics 2016 in just 1 week on 15th and 16th February in Central London...
